The company played up certain results, but investors focused on the weak spots

Sangamo Therapeutics Inc. stock dropped 23.6% in extremely active Wednesday trade after the company released early results from a gene-editing trial for a rare metabolic disorder called Hunter syndrome. Shares continued their fall on Thursday, dropping 4.6%.

The size of the country’s middle class remained stable, but financial gains were modest

While the lower and upper classes have increased in size over the past decade, the once-shrinking American middle class appears to holding ground.

Millennials may be flocking to bitcoin rather than investing in more traditional assets, but most Americans might want to take a class in the cryptocurrency.

At the anniversary of the Equifax Inc. breach disclosure, the biggest headache for executives in charge of protecting company data has to do with choices — as in, way too many of them.

Strategist: ‘The eurozone has underperformed — true — but it’s not exceptionally cheap’

Some bargain hunters say they’ve spotted a good deal as they check out Europe’s broad stock gauges.

Australian dollar sinks to 2 1/2-year low

A whiff of accelerating wage growth provided a modest lift for the U.S. currency Friday, putting a closely watched dollar index on track for a weekly gain.

This healthcare REIT, gold stock, and solar power play are on these investors’ radar right now.

Find out the latest for this much-loved way of picking blue-chip dividend stocks.

Wall Street’s major indexes fell on Friday as U.S. President raised the possibility of additional tariffs on Chinese imports and Apple Inc indicated that some of its products could be subjected to such levies.

Shares of Five Below skyrocketed more than 13 percent to an all-time high on Friday, the day after the company reported sales that easily beat expectations, boosting its bottom line.